Refractory WHO Grade II Glioma
1 clinical trials · Condition
◉ Watch Refractory WHO Grade II Glioma
| Record | Firm | Date |
|---|---|---|
| Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma (NCT02208362) | City of Hope Medical Center | 2015-05-18 |
Track Refractory WHO Grade II Glioma automatically
Every clearance here is in the API, with alerts when new ones post.